KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹844 Cr | ₹743 Cr | ₹650 Cr | ₹611 Cr | ₹439 Cr |
What is the latest Total Liabilities ratio of KOPRAN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹844 Cr |
| Mar2024 | ₹743 Cr |
| Mar2023 | ₹650 Cr |
| Mar2022 | ₹611 Cr |
| Mar2021 | ₹439 Cr |
How is Total Liabilities of KOPRAN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹844 Cr | 13.56 | |
| Mar2024 | ₹743 Cr | 14.40 | |
| Mar2023 | ₹650 Cr | 6.35 | |
| Mar2022 | ₹611 Cr | 39.03 | |
| Mar2021 | ₹439 Cr | - | |
Compare Total Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹800.3 Cr | -0.7% | -4.9% | -42.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -0.7% |
-4.9% |
-42.6% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses